Business Insider |
Sanofi: Diabetes treatment sees positive results
MarketWatch Sanofi is seeking alternative diabetes treatment as it faces rising competition in that market since its insulin Lantus lost patent protection in the U.S. in May. Sanofi's diabetes drug sales, which account for more than 20% of the company's revenue … Sanofi breaks news of positive results for combination diabetes drugNature World Report Sanofi's combination diabetes drug hits goal in second late-stage trialBusiness Insider Sanofi (SNY) Announces LixiLan-L Phase III Met Primary Endpoint in Certain …StreetInsider.com PPP Focus.com all 62 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.